TOLERANCE OF ONE-MONTH INTRANASAL INTERFERON

被引：21

作者：

SCOTT, GM

ONWUBALILI, JK

ROBINSON, JA

DORE, C

SECHER, DS

CANTELL, K

机构：

[1] MRC,CLIN RES CTR,DIV COMMUNICABLE DIS,HARROW HA1 3UJ,MIDDX,ENGLAND

[2] MRC,CLIN RES CTR,DIV COMP & STAT,HARROW HA1 3UJ,MIDDX,ENGLAND

[3] CENT PUBL HLTH LAB,SF-00280 HELSINKI 28,FINLAND

[4] LAB MOLEC BIOL,CAMBRIDGE,ENGLAND

来源：

关键词：

D O I：

10.1002/jmv.1890170202

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：99 / 106

页数：8

共 15 条

[1] BEARE AS, 1977, CHEMOPROPHYLAXIS VIR, V2, P27
[2] BETTS RF, 1983, P INT C CHEMOTHERAPY, V6, P1
[3] Cantell K, 1981, Methods Enzymol, V78, P29
[4] FARR B, 1983, ANTIMICROB AGENTS CH, V26, P31
[5] HUMAN TOLERANCE AND HISTOPATHOLOGIC EFFECTS OF LONG-TERM ADMINISTRATION OF INTRANASAL INTERFERON-ALPHA-2
HAYDEN, FG
MILLS, SE
JOHNS, ME
[J]. JOURNAL OF INFECTIOUS DISEASES, 1983, 148 (05) : 914 - 921
[6] HERZOG C, 1983, LANCET, V2, P962
[7] INTRANASAL INTERFERON AS PROTECTION AGAINST EXPERIMENTAL RESPIRATORY CORONAVIRUS INFECTION IN VOLUNTEERS
HIGGINS, PG
PHILLPOTTS, RJ
SCOTT, GM
WALLACE, J
BERNHARDT, LL
TYRRELL, DAJ
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) : 713 - 715
[8] MERIGAN T C, 1973, Lancet, V1, P563
[9] AN EFFECTIVE DOSAGE REGIMEN FOR PROPHYLAXIS AGAINST RHINOVIRUS INFECTION BY INTRANASAL ADMINISTRATION OF HUIFN-ALPHA-2
PHILLPOTTS, RJ
SCOTT, GM
HIGGINS, PG
WALLACE, J
TYRRELL, DAJ
GAUCI, CL
[J]. ANTIVIRAL RESEARCH, 1983, 3 (02) : 121 - 136
[10] PRIESTMAN TJ, 1980, LANCET, V2, P113